|
1
|
Bruni L, Barrionuevo-Rosas L, Albero G,
Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX and de Sanjosé S: ICO
information centre on HPV and cancer (HPV Information Centre).
Human papillomavirus and related diseases in the World. Summary
Report. 30–July;2017.
|
|
2
|
Bruni L, Barrionuevo-Rosas L, Albero G,
Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX and de Sanjosé S: ICO
information centre on HPV and cancer (HPV Information Centre).
Human papillomavirus and related diseases in Asia. Summary Report.
27–July;2017.
|
|
3
|
Li N, Franceschi S, Howell-Jones R,
Snijders PJ and Clifford GM: Human papillomavirus type distribution
in 30,848 invasive cervical cancers worldwide: Variation by
geographical region, histological type and year of publication. Int
J Cancer. 128:927–935. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu EQ, Yu XH, Zha X, Zhang GN, Wang JH,
Fan Y, Tang YY, Zhao ZX, Wu YG and Kong W: Distribution of human
papillomavirus genotypes in archival cervical lesions in eastern
inner Mongolian autonomous region. China Int J Gynecol Cancer.
19:919–923. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Youssef MA, Abdelsalam L, Harfoush RA,
Talaat IM, Elkattan E, Mohey A, Abdella RM, Farhan MS, Foad HA,
Elsayed AM, et al: Prevalence of human papilloma virus (HPV) and
its genotypes in cervical specimens of Egyptian women by linear
array HPV genotyping test. Infect Agent Cancer. 11:1750–9378. 2016.
View Article : Google Scholar
|
|
6
|
Téguété I, Dolo A, Sangare K, Sissoko A,
Rochas M, Beseme S, Tounkara K, Yekta S, De Groot AS and Koita OA:
Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination
trials in patients with cervical cancer in Mali. PLoS One.
12:e01726612017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siddiqa A, Zainab M, Qadri I, Bhatti MF
and Parish JL: Prevalence and genotyping of high risk human
papillomavirus in cervical cancer samples from Punjab, Pakistan.
Viruses. 6:2762–2777. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suthipintawong C, Siriaunkgul S,
Tungsinmunkong K, Pientong C, Ekalaksananan T, Karalak A, Kleebkaow
P, Vinyuvat S, Triratanachat S, Khunamornpong S and Chongsuwanich
T: Human papilloma virus prevalence, genotype distribution, and
pattern of infection in Thai women. Asian Pac J Cancer Prev.
12:853–856. 2011.PubMed/NCBI
|
|
9
|
Chaturvedi AK, Katki HA, Hildesheim A,
Rodríguez AC, Quint W, Schiffman M, Van Doorn LJ, Porras C,
Wacholder S, Gonzalez P, et al: Human papillomavirus infection with
multiple types: Pattern of coinfection and risk of cervical
disease. J Infect Dis. 203:910–920. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trottier H, Mahmud S, Costa MC, Sobrinho
JP, Duarte- Franco E, Rohan TE, Ferenczy A, Villa LL and Franco EL:
Human papillomavirus infections with multiple types and risk of
cervical neoplasia. Cancer Epidemiol Biomark Prev. 15:1274–1280.
2006. View Article : Google Scholar
|
|
11
|
Salazar KL, Zhou HS, Xu J, Peterson LE,
Schwartz MR, Mody DR and Ge Y: Multiple human papilloma virus
infections and their impact on the development of high-risk
cervical lesions. Acta Cytol. 59:391–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pett M and Coleman N: Integration of
high-risk human papillomavirus: A key event in cervical
carcinogenesis? J Pathol. 212:356–367. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cricca M, Morselli-Labate AM, Venturoli S,
Ambretti S, Gentilomi GA, Gallinella G, Costa S, Musiani M and
Zerbini M: Viral DNA load, physical status and E2/E6 ratio as
markers to grade HPV16 positive women for high-grade cervical
lesions. Gynecol Oncol. 106:549–557. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu EQ, Zha X, Yu XH, Zhang GN, Wu YG, Fan
Y, Ren Y, Kong LQ and Kong W: Profile of physical status and gene
variation of human papillomavirus 58 genome in cervical cancer. J
Gen Virol. 90:1229–1237. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qureshi MN, Bolick D, Ringer PJ, Spagler
FL and Zimmerman G: HPV testing in liquid cytology specimens:
Comparison of analytic sensitivty and specificity for in situ
hybridization and chemiluminescent nucleic acid testing. Acta
Cytol. 49:120–126. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fujii T, Masumoto N, Saito M, Hirao N,
Niimi S, Mukai M, Ono A, Hayashi S, Kubushiro K, Sakai E, et al:
Comparison between in situ hybridization and real-time PCR
technique as a means of detecting the integrated form of human
papillomavirus 16 in cervical neoplasia. Diagn Mol Pathol.
14:103–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chaiwongkot A, Pientong C, Ekalaksananan
T, Vinokurova S, Kongyingyoes B, Chumworathayi B, Patarapadungkit
N, Siriaunkgul S and von Knebel Doeberitz M: Detection of the human
papillomavirus 58 physical state using the amplification of
papillomavirus oncogene transcripts assay. J Virol Methods.
189:290–298. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wanram S, Limpaiboon T, Leelayuwat C,
Yuenyao P, Guiney DG, Lulitanond V, Lulitanond V and Jearanaikoon
P: The use of viral load as a surrogate marker in predicting
disease progression for patients with early invasive cervical
cancer with integrated human papillomavirus type 16. Am J Obstet
Gynecol. 201:79.e1–e7. 2009. View Article : Google Scholar
|
|
19
|
Sotlar K, Diemer D, Dethleffs A, Hack Y,
Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, et
al: Detection and typing of human papillomavirus by E6 nested
multiplex PCR. J Clin Microbiol. 42:3176–3184. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peitsaro P, Johansson B and Syrjanen S:
Integrated human papillomavirus type 16 is frequently found in
cervical cancer precursors as demonstrated by a novel quantitative
real-time PCR technique. J Clin Microbiol. 40:886–891. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Damay A, Didelot-Rousseau MN, Costes V,
Konate I, Ouedraogo A, Nagot N, Foulongne V, Van de Perre P, Mayaud
P and Segondy M: Viral load and physical status of human
papillomavirus (HPV) 18 in cervical samples from female sex workers
infected with HPV 18 in Burkina Faso. J Med Virol. 81:1786–1791.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bustin SA, Benes V, Garson JA, Hellemans
J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL,
et al: The MIQE guidelines: Minimum information for publication of
quantitative real-time PCR experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Broeders S, Huber I, Grohmann L, Berben G,
Taverniers I, Mazzara M, Roosens N and Morisset D: Guidelines for
validation of qualitative real-time PCR methods. Trends Food Sci
Technol. 37:115–126. 2014. View Article : Google Scholar
|
|
24
|
Munagala R, Donà MG, Rai SN, Jenson AB,
Bala N, Ghim SJ and Gupta RC: Significance of multiple HPV
infection in cervical cancer patients and its impact on treatment
response. Int J Oncol. 34:263–271. 2009.PubMed/NCBI
|
|
25
|
Zhao Y, Cao X, Tang J, Zhou L, Gao Y, Wang
J, Zheng Y, Yin S and Wang Y: A novel multiplex real-time PCR assay
for the detection and quantification of HPV16/18 and HSV1/2 in
cervical cancer screening. Mol Cell Probes. 26:66–72. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bruni L, Barrionuevo-Rosas L, Albero G,
Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX and de Sanjosé S: ICO
Information Centre on HPV and Cancer (HPV information centre).
Human papillomavirus and related diseases in Thailand. Summary
Report. 27–July;2017.
|
